Rubric Capital Management LP - Q2 2019 holdings

$1.27 Billion is the total value of Rubric Capital Management LP's 54 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .

 Value Shares↓ Weighting
AMBC ExitAMBAC FINL GROUP INC$0-70,096
-100.0%
-0.12%
PRTY ExitPARTY CITY HOLDCO INC$0-174,600
-100.0%
-0.13%
ZYME ExitZYMEWORKS INC$0-162,318
-100.0%
-0.24%
GMS ExitGMS INC$0-241,261
-100.0%
-0.34%
ENS ExitENERSYS$0-73,000
-100.0%
-0.44%
BC ExitBRUNSWICK CORP$0-95,000
-100.0%
-0.45%
AKBA ExitAKEBIA THERAPEUTICS INC$0-604,481
-100.0%
-0.46%
MGNX ExitMACROGENICS INC$0-282,200
-100.0%
-0.47%
MUR ExitMURPHY OIL CORP$0-200,000
-100.0%
-0.55%
AERI ExitAERIE PHARMACEUTICALS INC$0-164,070
-100.0%
-0.73%
MGY ExitMAGNOLIA OIL & GAS CORPcl a$0-742,477
-100.0%
-0.83%
SAFM ExitSANDERSON FARMS INC$0-77,337
-100.0%
-0.95%
AGN ExitALLERGAN PLC$0-70,400
-100.0%
-0.96%
DAL ExitDELTA AIR LINES INC DEL$0-199,924
-100.0%
-0.96%
MDRIQ ExitMCDERMOTT INTL INCcall$0-1,760,700
-100.0%
-1.22%
AVYA ExitAVAYA HLDGS CORP$0-1,160,004
-100.0%
-1.82%
SYNH ExitSYNEOS HEALTH INCcl a$0-446,705
-100.0%
-2.16%
IGT ExitINTERNATIONAL GAME TECHNOLOG$0-1,869,904
-100.0%
-2.27%
J ExitJACOBS ENGR GROUP INC$0-335,100
-100.0%
-2.35%
CFX ExitCOLFAX CORP$0-1,012,787
-100.0%
-2.81%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-707,952
-100.0%
-3.40%
HRTX ExitHERON THERAPEUTICS INC$0-1,500,000
-100.0%
-3.42%
BERY ExitBERRY GLOBAL GROUP INC$0-701,899
-100.0%
-3.53%
ARNA ExitARENA PHARMACEUTICALS INC$0-857,103
-100.0%
-3.59%
MYL ExitMYLAN N V$0-1,700,000
-100.0%
-4.50%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAGNACHIP SEMICONDUCTOR CORP28Q3 20234.7%
BGC PARTNERS INC20Q2 20234.6%
MR COOPER GROUP INC20Q3 20235.9%
PAR PACIFIC HOLDINGS INC18Q3 20233.9%
RADIUS HEALTH INC16Q2 20224.3%
CLEAR CHANNEL OUTDOOR HLDGS16Q3 20232.6%
HERON THERAPEUTICS INC15Q3 20239.0%
COLLEGIUM PHARMACEUTICAL INC15Q3 20233.9%
AAR CORP14Q3 20233.2%
GREEN PLAINS INC14Q3 20224.1%

View Rubric Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Rubric Capital Management LP Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/July 25, 202326,713,50319.0%
Amryt Pharma plcFebruary 10, 202318,000,0005.6%
BGC Partners, Inc.February 10, 202318,250,0005.6%
EverQuote, Inc.February 10, 20231,246,6224.8%
Ferroglobe PLCFebruary 10, 20233,232,7621.7%
Sio Gene Therapies Inc.February 10, 20237,000,0009.5%
Vincerx Pharma, Inc.February 10, 2023386,7191.8%
Whole Earth Brands, Inc.February 10, 2023998,3632.4%
Radius Health, Inc.June 16, 20226,959,30514.6%
ANTARES PHARMA, INC.February 14, 202210,800,0006.4%

View Rubric Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
DFAN14A2024-05-16
13F-HR2024-05-10
DFAN14A2024-05-08
DFAN14A2024-05-03
DFAN14A2024-05-01
DFAN14A2024-04-30
DFAN14A2024-04-29
DEFC14A2024-04-17
DFAN14A2024-04-17
SC 13D/A2024-04-16

View Rubric Capital Management LP's complete filings history.

Compare quarters

Export Rubric Capital Management LP's holdings